3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Status
Completed
1
Sponsor Class
INDUSTRY
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gynecologic
1
Conditions
Ovarian Neoplasms
1
Metastatic Castration Resistant Prostate Cancer
1
Mental Retardation, X-Linked, With Or Without Seizures, Arx-Related
1
Fallopian Tube Neoplasms
1
Interventions
Paclitaxel
3
mirvetuximab soravtansine
2
Bevacizumab
2
rucaparib
1
relacorilant
1
pembrolizumab
1
liposomal doxorubicin
1
Topotecan
1
Taxes
1
Saline Solution
1
Immunoglobulin G
1
Glucose
1
Docetaxel
1
Disulfides
1
Carboplatin
1
130-nm albumin-bound paclitaxel
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Has announcements
×
Fallopian Tube Neoplasms
×
rucaparib
×
Clear all
NCT01968213
2023-06-09
ARIEL3
pharmaand GmbH
Phase 3
Completed
564 enrolled
18 charts
1 FDA